Pre-earnings options volume in Sellas Life Sciences (SLS) is normal with calls leading puts 142:1. Implied volatility suggests the market is anticipating a move near 12.3%, or 19c, after results are released. Median move over the past eight quarters is 5.5%.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLS:
- SLS Upcoming Earnings Report: What to Expect?
- Promising Clinical Developments and Strong Financial Position Bolster Buy Rating for SELLAS Life Sciences
- Largest borrow rate increases among liquid names
- Unusually active option classes on open October 27th
- SELLAS Life Sciences Enters Warrant Inducement Agreement